Tissue microarrays constructed from ccRCC samples by immunohistochemistry were used to determine the differential expression status of FDX1 associated with clinicopathological characteristics, and a Cox regression model was built for survival analysis. The gene discussed is FDX1; the disease is nonpapillary renal cell carcinoma.